Machine-learning methods for ligand–protein molecular docking

K Crampon, A Giorkallos, M Deldossi, S Baud… - Drug discovery today, 2022 - Elsevier
Artificial intelligence (AI) is often presented as a new Industrial Revolution. Many domains
use AI, including molecular simulation for drug discovery. In this review, we provide an …

Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD)

JW Lee, MA Maria-Solano, TNL Vu… - Biochemical Society …, 2022 - portlandpress.com
There have been numerous advances in the development of computational and statistical
methods and applications of big data and artificial intelligence (AI) techniques for computer …

Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors

A Gasmi, S Noor, A Menzel, L Pivina… - Current medicinal …, 2021 - ingentaconnect.com
Background: Obesity is known to be a multifactorial disease. In its pathogenesis, different
factors such as chronic inflammation, oxidative stress, insulin resistance, genetic factors …

Inhibiting CDK6 activity by quercetin is an attractive strategy for cancer therapy

M Yousuf, P Khan, A Shamsi, M Shahbaaz… - ACS …, 2020 - ACS Publications
Cyclin-dependent kinase 6 (CDK6) is a potential drug target that plays an important role in
the progression of different types of cancers. We performed in silico and in vitro screening of …

Evolution of CRISPR/cas systems for precise genome editing

M Hryhorowicz, D Lipiński, J Zeyland - International Journal of Molecular …, 2023 - mdpi.com
The bacteria-derived CRISPR/Cas (an acronym for regularly interspaced short palindromic
repeats/CRISPR-associated protein) system is currently the most widely used, versatile, and …

Deep learning in drug design: protein-ligand binding affinity prediction

MA Rezaei, Y Li, D Wu, X Li, C Li - IEEE/ACM transactions on …, 2020 - ieeexplore.ieee.org
Computational drug design relies on the calculation of binding strength between two
biological counterparts especially a chemical compound, ie, a ligand, and a protein …

The impact of compound library size on the performance of scoring functions for structure-based virtual screening

L Fresnais, PJ Ballester - Briefings in bioinformatics, 2021 - academic.oup.com
Larger training datasets have been shown to improve the accuracy of machine learning (ML)-
based scoring functions (SFs) for structure-based virtual screening (SBVS). In addition …

[HTML][HTML] Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure–activity relationship-based artificial intelligence and molecular docking of hit …

O Hermansyah, A Bustamam, A Yanuar - Computational Biology and …, 2021 - Elsevier
Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors are becoming an essential drug in the
treatment of type 2 diabetes mellitus; however, some classes of these drugs exert side …

Computational investigation of novel farnesyltransferase inhibitors using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking and molecular …

A Safavi, ES Ghodousi, M Ghavamizadeh… - Journal of Molecular …, 2021 - Elsevier
Farnesyltransferase (FTase) is considered as an effective target in treating a variety of
cancers. In this investigation, a 3D-QSAR pharmacophore search was performed to identify …

Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases

NA Lashgari, NM Roudsari, S Momtaz… - Current Medicinal …, 2021 - ingentaconnect.com
Inflammatory bowel disease (IBD) is a general term for a group of chronic and progressive
disorders. Several cellular and biomolecular pathways are implicated in the pathogenesis of …